Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials

Basal insulin peglispro (BIL) is a novel basal insulin with hepato‐preferential action, resulting from reduced peripheral effects. This report summarizes hypoglycaemia data from five BIL phase III studies with insulin glargine as the comparator, including three double‐blind trials. Prespecified pool...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Rosenstock, Julio, Marre, Michel, Qu, Yongming, Zhang, Shuyu, Bastyr, Edward J., Prince, Melvin J., Chang, Annette M.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2016
Assuntos:
Themed Section‐bil
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5096011/
https://ncbi.nlm.nih.gov/pubmed/27484021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12757
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados